chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 74.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect dose administered
Clinical narrative: We administered half the dose (0.25 ml) instead of 0.5 ml
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Reporting on behalf of facility. Aggregate Report per COVID-19 Vaccine Information Brief dated 9/9/2022. Monovalent COVID vaccine administered as booster after FDA authorization. Ten patients were given Moderna monovalent COVID vaccine after FDA authorization of bivalent booster. Dates 9/2/2022 - 9/7/2022. Delay and confusion regarding vaccine information brief. Since that time, bivalent boosters received and provider/staff education provided. Please let me know if you have any additional questions. Thank you.
Age: 44.0
Sex: M
Vaccine: COVID19-2
Symptoms: Underdose
Clinical narrative: We administered half the dose (0.25 ml) instead of 0.5 ml
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Agitation, Angiogram pulmonary abnormal, Blood creatinine increased, Blood lactic acid
Clinical narrative: Discharge Provider: MD Primary Care Physician at Discharge: PA-C Admission Date: 9/8/2022  PRESENTING PROBLEM: Shock    HOSPITAL COURSE: Patient is a 85 year old with a past medical history Rheumatoid arthritis ( on Prednisone), HTN, Anemia, Chronic Back pain ( see the pain clinic), HFrEF (EF 20%) who presented to ED via EMS from her home with Shortness of breath and chest pain. Per documentation, she had worsening SOB and a productive cough since 9/4. Today she developed respiratory distress which prompted the call to EMS. En route, she received ASA and nitro x1. In the ED, she was found to be Covid PCR (+). CTA thorax negative for PE, new T7 compression fracture, thyroid nodules > 17 mm, Large hiatal hernia, incidental cholelithiasis. Significant labs noted: Troponins > 300, creatinine > 2, BNP 9.5K. Due to the concern for NSTEMI, the ED physician spoke with cardiology- PA-C. Due to low hemoglobin at 10g/dL, plan to hold on starting AC at this time. Due to patient's refractory hypotension, she was started on NE and transferred to ICU for management. Plan to obtain Echo.  Pt continued to decompensate overnight, Epi was added for presumred cardiogenic shock, mixed venous only 50, vaso added for ongoing hypotension.  Pt agitated, bipap placed, precedex started.  Haldol given.  Troponin rising, rpt lactic 7.  Family updated and came to pt bedside, after further discussion the decision was made to place patient on comfort care and withdrawal life saving medications. Patient pronounced dead at 1743. Please see death note for additional details.   Date of Death: 9/9/22 Time of Death:  5:43 PM Preliminary Cause of Death: Acute hypoxemic respiratory failure due to COVID-19
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Brain natriuretic peptide increased, COVID-19, Cardiogenic shock, Chest pain, Cholelithiasis
Clinical narrative: Discharge Provider: MD Primary Care Physician at Discharge: PA-C Admission Date: 9/8/2022  PRESENTING PROBLEM: Shock    HOSPITAL COURSE: Patient is a 85 year old with a past medical history Rheumatoid arthritis ( on Prednisone), HTN, Anemia, Chronic Back pain ( see the pain clinic), HFrEF (EF 20%) who presented to ED via EMS from her home with Shortness of breath and chest pain. Per documentation, she had worsening SOB and a productive cough since 9/4. Today she developed respiratory distress which prompted the call to EMS. En route, she received ASA and nitro x1. In the ED, she was found to be Covid PCR (+). CTA thorax negative for PE, new T7 compression fracture, thyroid nodules > 17 mm, Large hiatal hernia, incidental cholelithiasis. Significant labs noted: Troponins > 300, creatinine > 2, BNP 9.5K. Due to the concern for NSTEMI, the ED physician spoke with cardiology- PA-C. Due to low hemoglobin at 10g/dL, plan to hold on starting AC at this time. Due to patient's refractory hypotension, she was started on NE and transferred to ICU for management. Plan to obtain Echo.  Pt continued to decompensate overnight, Epi was added for presumred cardiogenic shock, mixed venous only 50, vaso added for ongoing hypotension.  Pt agitated, bipap placed, precedex started.  Haldol given.  Troponin rising, rpt lactic 7.  Family updated and came to pt bedside, after further discussion the decision was made to place patient on comfort care and withdrawal life saving medications. Patient pronounced dead at 1743. Please see death note for additional details.   Date of Death: 9/9/22 Time of Death:  5:43 PM Preliminary Cause of Death: Acute hypoxemic respiratory failure due to COVID-19
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Death, Dyspnoea, General physical health deterioration, Haemoglobin decreased, Hiatus hernia
Clinical narrative: Discharge Provider: MD Primary Care Physician at Discharge: PA-C Admission Date: 9/8/2022  PRESENTING PROBLEM: Shock    HOSPITAL COURSE: Patient is a 85 year old with a past medical history Rheumatoid arthritis ( on Prednisone), HTN, Anemia, Chronic Back pain ( see the pain clinic), HFrEF (EF 20%) who presented to ED via EMS from her home with Shortness of breath and chest pain. Per documentation, she had worsening SOB and a productive cough since 9/4. Today she developed respiratory distress which prompted the call to EMS. En route, she received ASA and nitro x1. In the ED, she was found to be Covid PCR (+). CTA thorax negative for PE, new T7 compression fracture, thyroid nodules > 17 mm, Large hiatal hernia, incidental cholelithiasis. Significant labs noted: Troponins > 300, creatinine > 2, BNP 9.5K. Due to the concern for NSTEMI, the ED physician spoke with cardiology- PA-C. Due to low hemoglobin at 10g/dL, plan to hold on starting AC at this time. Due to patient's refractory hypotension, she was started on NE and transferred to ICU for management. Plan to obtain Echo.  Pt continued to decompensate overnight, Epi was added for presumred cardiogenic shock, mixed venous only 50, vaso added for ongoing hypotension.  Pt agitated, bipap placed, precedex started.  Haldol given.  Troponin rising, rpt lactic 7.  Family updated and came to pt bedside, after further discussion the decision was made to place patient on comfort care and withdrawal life saving medications. Patient pronounced dead at 1743. Please see death note for additional details.   Date of Death: 9/9/22 Time of Death:  5:43 PM Preliminary Cause of Death: Acute hypoxemic respiratory failure due to COVID-19
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension, Intensive care, Positive airway pressure therapy, Productive cough, Respiratory distress
Clinical narrative: Discharge Provider: MD Primary Care Physician at Discharge: PA-C Admission Date: 9/8/2022  PRESENTING PROBLEM: Shock    HOSPITAL COURSE: Patient is a 85 year old with a past medical history Rheumatoid arthritis ( on Prednisone), HTN, Anemia, Chronic Back pain ( see the pain clinic), HFrEF (EF 20%) who presented to ED via EMS from her home with Shortness of breath and chest pain. Per documentation, she had worsening SOB and a productive cough since 9/4. Today she developed respiratory distress which prompted the call to EMS. En route, she received ASA and nitro x1. In the ED, she was found to be Covid PCR (+). CTA thorax negative for PE, new T7 compression fracture, thyroid nodules > 17 mm, Large hiatal hernia, incidental cholelithiasis. Significant labs noted: Troponins > 300, creatinine > 2, BNP 9.5K. Due to the concern for NSTEMI, the ED physician spoke with cardiology- PA-C. Due to low hemoglobin at 10g/dL, plan to hold on starting AC at this time. Due to patient's refractory hypotension, she was started on NE and transferred to ICU for management. Plan to obtain Echo.  Pt continued to decompensate overnight, Epi was added for presumred cardiogenic shock, mixed venous only 50, vaso added for ongoing hypotension.  Pt agitated, bipap placed, precedex started.  Haldol given.  Troponin rising, rpt lactic 7.  Family updated and came to pt bedside, after further discussion the decision was made to place patient on comfort care and withdrawal life saving medications. Patient pronounced dead at 1743. Please see death note for additional details.   Date of Death: 9/9/22 Time of Death:  5:43 PM Preliminary Cause of Death: Acute hypoxemic respiratory failure due to COVID-19
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Shock, Spinal compression fracture, Thyroid mass, Troponin
Clinical narrative: Discharge Provider: MD Primary Care Physician at Discharge: PA-C Admission Date: 9/8/2022  PRESENTING PROBLEM: Shock    HOSPITAL COURSE: Patient is a 85 year old with a past medical history Rheumatoid arthritis ( on Prednisone), HTN, Anemia, Chronic Back pain ( see the pain clinic), HFrEF (EF 20%) who presented to ED via EMS from her home with Shortness of breath and chest pain. Per documentation, she had worsening SOB and a productive cough since 9/4. Today she developed respiratory distress which prompted the call to EMS. En route, she received ASA and nitro x1. In the ED, she was found to be Covid PCR (+). CTA thorax negative for PE, new T7 compression fracture, thyroid nodules > 17 mm, Large hiatal hernia, incidental cholelithiasis. Significant labs noted: Troponins > 300, creatinine > 2, BNP 9.5K. Due to the concern for NSTEMI, the ED physician spoke with cardiology- PA-C. Due to low hemoglobin at 10g/dL, plan to hold on starting AC at this time. Due to patient's refractory hypotension, she was started on NE and transferred to ICU for management. Plan to obtain Echo.  Pt continued to decompensate overnight, Epi was added for presumred cardiogenic shock, mixed venous only 50, vaso added for ongoing hypotension.  Pt agitated, bipap placed, precedex started.  Haldol given.  Troponin rising, rpt lactic 7.  Family updated and came to pt bedside, after further discussion the decision was made to place patient on comfort care and withdrawal life saving medications. Patient pronounced dead at 1743. Please see death note for additional details.   Date of Death: 9/9/22 Time of Death:  5:43 PM Preliminary Cause of Death: Acute hypoxemic respiratory failure due to COVID-19
Age: 59.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Syncope
Clinical narrative: Pt had syncopal episode for 1-3 seconds. Able to regains to self after. Pt claims had previous event every time having injection done. No other medical conditions claimed.
Age: 47.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect dose administered
Clinical narrative: We administered half the dose (0.25 ml) instead of 0.5 ml
Age: 49.0
Sex: M
Vaccine: COVID19-2
Symptoms: Unevaluable event
Clinical narrative: None stated.
Age: 10.0
Sex: M
Vaccine: MNQ
Symptoms: Extra dose administered
Clinical narrative: I had given patient vaccine with out rechecking to see if he needed it. I will take precautions before giving vaccines.
Age: 63.0
Sex: F
Vaccine: FLU4
Symptoms: Diarrhoea, Vomiting, Wrong product administered
Clinical narrative: pt is 63 and should have gotten fluzone quad.  I gave her the fluzone hd by mistake . when I called her at 1:45 pm today to let her know, she said she had vomiting and diarrhea and was on the floor.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Agitation, Alcohol test negative, Back pain, COVID-19, Chest X-ray normal
Clinical narrative: Discharge Provider: DO Primary Care Provider at Discharge: DO   Admission Date: 9/8/2022 Discharge Date: 9/10/2022 PRESENTING PROBLEM: Acute metabolic encephalopathy HOSPITAL COURSE: 54 yo with HTN, DMTII, seizures, CKD, CVA, COPD on oxygen, chronic pain brought to ED 9/7 for AMS. She was found to be hypercapnic with low GCS for which she was intubated. COVID positive without infiltrates on CXR. Drug screen neg for drugs of abuse and alcohol level was negative. She had post intubation shock for which she required norepi. 9/8 pm, she self extubated. She did require precedex overnight for agitation which was only transient and with appropriate behavior.    Recently prescribed baclofen, Lyrica, and Flagyl for back/vaginal pain. Negative head CT - history of CVA November of 2021 - managed with aspirin and statin therapy. Seen by Neurology exam without focal deficits, defer further neuroimaging. EEG with encephalopathy. Stop baclofen and lyrica.   Patient transferred out of the intensive care unit to the general medical floor.  She is breathing at her baseline oxygen level and requesting to go home as soon as possible.  Mobilizing without difficulty in the room.  Labs unremarkable this morning.  Sputum did return with MRSA and due to severe episode will elect to treat for 5 days.  Allergy to sulfa therefore prescribed doxycycline.   At time of discharge, patient is hemodynamically stable and insistent on leaving asap.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Coma scale, Computerised tomogram head normal, Drug screen negative, Electroencephalogram abnormal, Endotracheal intubation
Clinical narrative: Discharge Provider: DO Primary Care Provider at Discharge: DO   Admission Date: 9/8/2022 Discharge Date: 9/10/2022 PRESENTING PROBLEM: Acute metabolic encephalopathy HOSPITAL COURSE: 54 yo with HTN, DMTII, seizures, CKD, CVA, COPD on oxygen, chronic pain brought to ED 9/7 for AMS. She was found to be hypercapnic with low GCS for which she was intubated. COVID positive without infiltrates on CXR. Drug screen neg for drugs of abuse and alcohol level was negative. She had post intubation shock for which she required norepi. 9/8 pm, she self extubated. She did require precedex overnight for agitation which was only transient and with appropriate behavior.    Recently prescribed baclofen, Lyrica, and Flagyl for back/vaginal pain. Negative head CT - history of CVA November of 2021 - managed with aspirin and statin therapy. Seen by Neurology exam without focal deficits, defer further neuroimaging. EEG with encephalopathy. Stop baclofen and lyrica.   Patient transferred out of the intensive care unit to the general medical floor.  She is breathing at her baseline oxygen level and requesting to go home as soon as possible.  Mobilizing without difficulty in the room.  Labs unremarkable this morning.  Sputum did return with MRSA and due to severe episode will elect to treat for 5 days.  Allergy to sulfa therefore prescribed doxycycline.   At time of discharge, patient is hemodynamically stable and insistent on leaving asap.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Hypercapnia, Intensive care, Intentional medical device removal by patient, Laboratory test normal, Mental status changes
Clinical narrative: Discharge Provider: DO Primary Care Provider at Discharge: DO   Admission Date: 9/8/2022 Discharge Date: 9/10/2022 PRESENTING PROBLEM: Acute metabolic encephalopathy HOSPITAL COURSE: 54 yo with HTN, DMTII, seizures, CKD, CVA, COPD on oxygen, chronic pain brought to ED 9/7 for AMS. She was found to be hypercapnic with low GCS for which she was intubated. COVID positive without infiltrates on CXR. Drug screen neg for drugs of abuse and alcohol level was negative. She had post intubation shock for which she required norepi. 9/8 pm, she self extubated. She did require precedex overnight for agitation which was only transient and with appropriate behavior.    Recently prescribed baclofen, Lyrica, and Flagyl for back/vaginal pain. Negative head CT - history of CVA November of 2021 - managed with aspirin and statin therapy. Seen by Neurology exam without focal deficits, defer further neuroimaging. EEG with encephalopathy. Stop baclofen and lyrica.   Patient transferred out of the intensive care unit to the general medical floor.  She is breathing at her baseline oxygen level and requesting to go home as soon as possible.  Mobilizing without difficulty in the room.  Labs unremarkable this morning.  Sputum did return with MRSA and due to severe episode will elect to treat for 5 days.  Allergy to sulfa therefore prescribed doxycycline.   At time of discharge, patient is hemodynamically stable and insistent on leaving asap.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Metabolic encephalopathy, Neurological examination normal, Procedural shock, SARS-CoV-2 test positive, Sputum culture positive
Clinical narrative: Discharge Provider: DO Primary Care Provider at Discharge: DO   Admission Date: 9/8/2022 Discharge Date: 9/10/2022 PRESENTING PROBLEM: Acute metabolic encephalopathy HOSPITAL COURSE: 54 yo with HTN, DMTII, seizures, CKD, CVA, COPD on oxygen, chronic pain brought to ED 9/7 for AMS. She was found to be hypercapnic with low GCS for which she was intubated. COVID positive without infiltrates on CXR. Drug screen neg for drugs of abuse and alcohol level was negative. She had post intubation shock for which she required norepi. 9/8 pm, she self extubated. She did require precedex overnight for agitation which was only transient and with appropriate behavior.    Recently prescribed baclofen, Lyrica, and Flagyl for back/vaginal pain. Negative head CT - history of CVA November of 2021 - managed with aspirin and statin therapy. Seen by Neurology exam without focal deficits, defer further neuroimaging. EEG with encephalopathy. Stop baclofen and lyrica.   Patient transferred out of the intensive care unit to the general medical floor.  She is breathing at her baseline oxygen level and requesting to go home as soon as possible.  Mobilizing without difficulty in the room.  Labs unremarkable this morning.  Sputum did return with MRSA and due to severe episode will elect to treat for 5 days.  Allergy to sulfa therefore prescribed doxycycline.   At time of discharge, patient is hemodynamically stable and insistent on leaving asap.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Staphylococcal infection, Staphylococcus test positive, Vulvovaginal pain
Clinical narrative: Discharge Provider: DO Primary Care Provider at Discharge: DO   Admission Date: 9/8/2022 Discharge Date: 9/10/2022 PRESENTING PROBLEM: Acute metabolic encephalopathy HOSPITAL COURSE: 54 yo with HTN, DMTII, seizures, CKD, CVA, COPD on oxygen, chronic pain brought to ED 9/7 for AMS. She was found to be hypercapnic with low GCS for which she was intubated. COVID positive without infiltrates on CXR. Drug screen neg for drugs of abuse and alcohol level was negative. She had post intubation shock for which she required norepi. 9/8 pm, she self extubated. She did require precedex overnight for agitation which was only transient and with appropriate behavior.    Recently prescribed baclofen, Lyrica, and Flagyl for back/vaginal pain. Negative head CT - history of CVA November of 2021 - managed with aspirin and statin therapy. Seen by Neurology exam without focal deficits, defer further neuroimaging. EEG with encephalopathy. Stop baclofen and lyrica.   Patient transferred out of the intensive care unit to the general medical floor.  She is breathing at her baseline oxygen level and requesting to go home as soon as possible.  Mobilizing without difficulty in the room.  Labs unremarkable this morning.  Sputum did return with MRSA and due to severe episode will elect to treat for 5 days.  Allergy to sulfa therefore prescribed doxycycline.   At time of discharge, patient is hemodynamically stable and insistent on leaving asap.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Thrombosis, Ultrasound Doppler abnormal
Clinical narrative: Six hours after injection,  a 2 inch x 1 inch bruise appeared above my elbow and a blood clot  in my upper arm.  They both resolved on their own in time.
Age: 48.0
Sex: F
Vaccine: COVID19-2
Symptoms: Unevaluable event
Clinical narrative: None stated.
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Lethargy, Ocular discomfort
Clinical narrative: 27 minutes after receiving the Pfizer 1st dose vaccine the patient began to experience headache, eye discomfort, and dizziness. At 4:53 pm  vital signs were taken BP 125/60, O2 99%, RR 16, HR 69. At 4:55pm patient was lethargic , ammonia inhalant was used, with arousal. Emergency number was called at 4:55, 2nd set of VS  was taken at 5:10 HR 75, O2 99.4, BP 110/70. EMT arrived at 5:10pm. Sister stated no history of allergies, and reactions to vaccines, at 5:15pm patient care transferred over to EMT.
Age: 56.0
Sex: M
Vaccine: UNK
Symptoms: Injection site discolouration, Injection site erythema, Injection site pruritus, Injection site rash, Injection site reaction
Clinical narrative: Local skin reaction at injection site, which began about one week after vaccination, and persists 6 weeks later, with erythematous rounded rash, raised edges, hyperpigmented center. Skin rash is itchy.
Age: 56.0
Sex: M
Vaccine: UNK
Symptoms: Injection site swelling, Skin reaction
Clinical narrative: Local skin reaction at injection site, which began about one week after vaccination, and persists 6 weeks later, with erythematous rounded rash, raised edges, hyperpigmented center. Skin rash is itchy.
Age: 55.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect dose administered
Clinical narrative: We administered half the dose (0.25 ml) instead of 0.5 ml
Age: 55.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect dose administered
Clinical narrative: We administered half the dose (0.25 ml) instead of 0.5 ml
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient vaccinated against then tested positive for COVID19
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Basedow's disease, Fibromyalgia
Clinical narrative: After Obtaining the first two doses of vaccinations I had gotten Graves disease & Fibromyalgia
Age: 47.0
Sex: F
Vaccine: COVID19-2, FLUC4
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: Swollen and painful lymph nodes in armpit and on neck.  On same side as injection so far, but this also happened with third shot (Moderna) and lymph nodes on opposite side near groin were affected.  (Did not report at that time)
Age: 52.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect dose administered
Clinical narrative: We administered 0.25 ml instead of 0.5 ml
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Bell's palsy, Facial paresis
Clinical narrative: Patient developed Bell's Palsy of the left side of face 5 days after the second dose of the vaccine.  Treatment with Prednisone was started on 9/15/22 with no signs of improvement in facial weakness. Treatment with Valtrex prescribed today, 9/20/22.
Age: 57.0
Sex: F
Vaccine: COVID19-2
Symptoms: Axillary pain, Breast pain, Discomfort, Sleep disorder, Swelling
Clinical narrative: Pain in right axillary area and right side of breast a little over 24 hours after vaccine.  Pain and swelling caused moderate discomfort about 6 on 1-10 scale and then by day 5 minimal pain just uncomfortable to sleep on that side
Age: 36.0
Sex: M
Vaccine: SMALLMNK, SMALLMNK
Symptoms: Wrong technique in product usage process
Clinical narrative: Wheal was not present upon administration.
Age: 59.0
Sex: F
Vaccine: FLUR4, FLUR4
Symptoms: Anaphylactic reaction, Loss of consciousness, Swollen tongue
Clinical narrative: anaphylaxis (passed out, swollen tongue)
Age: 59.0
Sex: F
Vaccine: FLUR4, FLUR4
Symptoms: Anaphylactic shock, Throat tightness
Clinical narrative: anaphylaxis (passed out, swollen tongue)
Age: 35.0
Sex: M
Vaccine: UNK
Symptoms: Incorrect product formulation administered
Clinical narrative: Monovalent vaccine was given instead of bivalent booster. per cdc, VAERs report must be filled out.
Age: 29.0
Sex: M
Vaccine: YF
Symptoms: Injection site erythema, Injection site induration, Injection site swelling, Injection site urticaria, Injection site warmth
Clinical narrative: Pt is a wiggler with vaccines and upon administration of the shot, patient moved and vaccine did not get injected. Upon further examination, injection site was indurated, red, puffy and warm with 5 raised areas. Over the next 10 minutes this transitioned into one massive hive with redness and swelling.
Age: 29.0
Sex: M
Vaccine: YF
Symptoms: Vaccination error
Clinical narrative: Pt is a wiggler with vaccines and upon administration of the shot, patient moved and vaccine did not get injected. Upon further examination, injection site was indurated, red, puffy and warm with 5 raised areas. Over the next 10 minutes this transitioned into one massive hive with redness and swelling.
Age: 59.0
Sex: F
Vaccine: COVID19-2, FLUR4
Symptoms: Cardiomyopathy, Echocardiogram abnormal, Pericarditis
Clinical narrative: Patient received COVID19 Pfizer bivalent and Flublok shots in separate arms on 9/15/22. On 9/17/22, pt experienced sudden onset cardiomyopathy/pericarditis and was taken to hospital via ambulance and admitted. Patient left hospital AMA on 9/18/22 and followed up with her PCP and cardiologist. Cardiologist prescribed nitroglycerine and colchicine to help with pericarditis. Pt is stable and at home now.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Anticoagulation drug level above therapeutic, Asthenia, Blood bicarbonate normal, Blood glucose increased
Clinical narrative: Admission Date: 9/8/2022 Discharge Date: 09/16/2022  PRESENTING PROBLEM: Generalized weakness Chronic renal impairment, stage 4 (severe) Hyperglycemia due to diabetes mellitus Hyperosmolar hyperglycemic state (HHS) COVID-19 virus infection   HOSPITAL COURSE: Patient is an 87 year old female with past medical history of NIDDM2, gout, PAF, mechanical aortic valve on coumadin, diastolic heart failure and CKD 4 who presented to ED to the ED with generalized fatigue. She had been on prednisone  for 10 days leading up to admission for gout flare. In the ED, pt was found to have BS of 659, sodium of 129, normal AG, bicarb. pH was elevated and beta hydroxybutyrate of 1.08. Her CBC showed leukocytosis of 18. COVID positive and CXR showed no acute process. She was admitted for further treatment.   She was started on endotool and director of medical services was consulted. She was transitioned to basal bolus on 9/9 but did continue to be hyperglycemic. Her a1c was found to be elevated to 12.1. The director of medical services assisted with management of basal bolus insulin. Recommendations to discharge on Novolog 70/30. The patient's husband is also on 70/30 at home and they feel comfortable with the management/administration of this. She should follow up with the director of medical services, or with her PCP for further management of DM.    Regarding COVID diagnosis, she remained stable on room air. She did not require remdesivir or decadron. She was noted to have supratherapeutic INR but no active signs of bleeding. No reversal agent given but coumadin held. She subsequently became subtherapeutic, and was placed on heparin gtt while awaiting therapeutic INR. She was not a candidate for lovenox given CKD. Once INR therapeutic x 2 consecutive days, she was felt stable for discharge home. She was advised to have her INR checked on Monday 9/19 as her lab is not open over the weekend.    PT/OT evaluated and recommended discharge home with assist and HHC. She was discharged home in stable condition with her husband on 9/16. All follow up recommendations discussed in detail with the patient and her husband prior to discharge.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Blood ketone body, Blood pH increased, Blood sodium decreased, COVID-19, Chest X-ray normal
Clinical narrative: Admission Date: 9/8/2022 Discharge Date: 09/16/2022  PRESENTING PROBLEM: Generalized weakness Chronic renal impairment, stage 4 (severe) Hyperglycemia due to diabetes mellitus Hyperosmolar hyperglycemic state (HHS) COVID-19 virus infection   HOSPITAL COURSE: Patient is an 87 year old female with past medical history of NIDDM2, gout, PAF, mechanical aortic valve on coumadin, diastolic heart failure and CKD 4 who presented to ED to the ED with generalized fatigue. She had been on prednisone  for 10 days leading up to admission for gout flare. In the ED, pt was found to have BS of 659, sodium of 129, normal AG, bicarb. pH was elevated and beta hydroxybutyrate of 1.08. Her CBC showed leukocytosis of 18. COVID positive and CXR showed no acute process. She was admitted for further treatment.   She was started on endotool and director of medical services was consulted. She was transitioned to basal bolus on 9/9 but did continue to be hyperglycemic. Her a1c was found to be elevated to 12.1. The director of medical services assisted with management of basal bolus insulin. Recommendations to discharge on Novolog 70/30. The patient's husband is also on 70/30 at home and they feel comfortable with the management/administration of this. She should follow up with the director of medical services, or with her PCP for further management of DM.    Regarding COVID diagnosis, she remained stable on room air. She did not require remdesivir or decadron. She was noted to have supratherapeutic INR but no active signs of bleeding. No reversal agent given but coumadin held. She subsequently became subtherapeutic, and was placed on heparin gtt while awaiting therapeutic INR. She was not a candidate for lovenox given CKD. Once INR therapeutic x 2 consecutive days, she was felt stable for discharge home. She was advised to have her INR checked on Monday 9/19 as her lab is not open over the weekend.    PT/OT evaluated and recommended discharge home with assist and HHC. She was discharged home in stable condition with her husband on 9/16. All follow up recommendations discussed in detail with the patient and her husband prior to discharge.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Diabetes mellitus management, Fatigue, Full blood count abnormal, Glycosylated haemoglobin increased
Clinical narrative: Admission Date: 9/8/2022 Discharge Date: 09/16/2022  PRESENTING PROBLEM: Generalized weakness Chronic renal impairment, stage 4 (severe) Hyperglycemia due to diabetes mellitus Hyperosmolar hyperglycemic state (HHS) COVID-19 virus infection   HOSPITAL COURSE: Patient is an 87 year old female with past medical history of NIDDM2, gout, PAF, mechanical aortic valve on coumadin, diastolic heart failure and CKD 4 who presented to ED to the ED with generalized fatigue. She had been on prednisone  for 10 days leading up to admission for gout flare. In the ED, pt was found to have BS of 659, sodium of 129, normal AG, bicarb. pH was elevated and beta hydroxybutyrate of 1.08. Her CBC showed leukocytosis of 18. COVID positive and CXR showed no acute process. She was admitted for further treatment.   She was started on endotool and director of medical services was consulted. She was transitioned to basal bolus on 9/9 but did continue to be hyperglycemic. Her a1c was found to be elevated to 12.1. The director of medical services assisted with management of basal bolus insulin. Recommendations to discharge on Novolog 70/30. The patient's husband is also on 70/30 at home and they feel comfortable with the management/administration of this. She should follow up with the director of medical services, or with her PCP for further management of DM.    Regarding COVID diagnosis, she remained stable on room air. She did not require remdesivir or decadron. She was noted to have supratherapeutic INR but no active signs of bleeding. No reversal agent given but coumadin held. She subsequently became subtherapeutic, and was placed on heparin gtt while awaiting therapeutic INR. She was not a candidate for lovenox given CKD. Once INR therapeutic x 2 consecutive days, she was felt stable for discharge home. She was advised to have her INR checked on Monday 9/19 as her lab is not open over the weekend.    PT/OT evaluated and recommended discharge home with assist and HHC. She was discharged home in stable condition with her husband on 9/16. All follow up recommendations discussed in detail with the patient and her husband prior to discharge.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Gout, Hyperglycaemia, Insulin therapy, Laboratory test normal, Leukocytosis
Clinical narrative: Admission Date: 9/8/2022 Discharge Date: 09/16/2022  PRESENTING PROBLEM: Generalized weakness Chronic renal impairment, stage 4 (severe) Hyperglycemia due to diabetes mellitus Hyperosmolar hyperglycemic state (HHS) COVID-19 virus infection   HOSPITAL COURSE: Patient is an 87 year old female with past medical history of NIDDM2, gout, PAF, mechanical aortic valve on coumadin, diastolic heart failure and CKD 4 who presented to ED to the ED with generalized fatigue. She had been on prednisone  for 10 days leading up to admission for gout flare. In the ED, pt was found to have BS of 659, sodium of 129, normal AG, bicarb. pH was elevated and beta hydroxybutyrate of 1.08. Her CBC showed leukocytosis of 18. COVID positive and CXR showed no acute process. She was admitted for further treatment.   She was started on endotool and director of medical services was consulted. She was transitioned to basal bolus on 9/9 but did continue to be hyperglycemic. Her a1c was found to be elevated to 12.1. The director of medical services assisted with management of basal bolus insulin. Recommendations to discharge on Novolog 70/30. The patient's husband is also on 70/30 at home and they feel comfortable with the management/administration of this. She should follow up with the director of medical services, or with her PCP for further management of DM.    Regarding COVID diagnosis, she remained stable on room air. She did not require remdesivir or decadron. She was noted to have supratherapeutic INR but no active signs of bleeding. No reversal agent given but coumadin held. She subsequently became subtherapeutic, and was placed on heparin gtt while awaiting therapeutic INR. She was not a candidate for lovenox given CKD. Once INR therapeutic x 2 consecutive days, she was felt stable for discharge home. She was advised to have her INR checked on Monday 9/19 as her lab is not open over the weekend.    PT/OT evaluated and recommended discharge home with assist and HHC. She was discharged home in stable condition with her husband on 9/16. All follow up recommendations discussed in detail with the patient and her husband prior to discharge.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, White blood cell count increased
Clinical narrative: Admission Date: 9/8/2022 Discharge Date: 09/16/2022  PRESENTING PROBLEM: Generalized weakness Chronic renal impairment, stage 4 (severe) Hyperglycemia due to diabetes mellitus Hyperosmolar hyperglycemic state (HHS) COVID-19 virus infection   HOSPITAL COURSE: Patient is an 87 year old female with past medical history of NIDDM2, gout, PAF, mechanical aortic valve on coumadin, diastolic heart failure and CKD 4 who presented to ED to the ED with generalized fatigue. She had been on prednisone  for 10 days leading up to admission for gout flare. In the ED, pt was found to have BS of 659, sodium of 129, normal AG, bicarb. pH was elevated and beta hydroxybutyrate of 1.08. Her CBC showed leukocytosis of 18. COVID positive and CXR showed no acute process. She was admitted for further treatment.   She was started on endotool and director of medical services was consulted. She was transitioned to basal bolus on 9/9 but did continue to be hyperglycemic. Her a1c was found to be elevated to 12.1. The director of medical services assisted with management of basal bolus insulin. Recommendations to discharge on Novolog 70/30. The patient's husband is also on 70/30 at home and they feel comfortable with the management/administration of this. She should follow up with the director of medical services, or with her PCP for further management of DM.    Regarding COVID diagnosis, she remained stable on room air. She did not require remdesivir or decadron. She was noted to have supratherapeutic INR but no active signs of bleeding. No reversal agent given but coumadin held. She subsequently became subtherapeutic, and was placed on heparin gtt while awaiting therapeutic INR. She was not a candidate for lovenox given CKD. Once INR therapeutic x 2 consecutive days, she was felt stable for discharge home. She was advised to have her INR checked on Monday 9/19 as her lab is not open over the weekend.    PT/OT evaluated and recommended discharge home with assist and HHC. She was discharged home in stable condition with her husband on 9/16. All follow up recommendations discussed in detail with the patient and her husband prior to discharge.
Age: 53.0
Sex: F
Vaccine: FLU4
Symptoms: Oxygen saturation decreased, Swelling, Swelling face, Tachycardia
Clinical narrative: Patient received Flu vaccine at 12:30pm. At home she had symptoms of tachycardia x 1 hour, oxygen level decrease 90% for 10 minutes, and  face & neck swelling from nose to neck area x 1 day. She took Benadryl 25mg with improvement.
Age: 64.0
Sex: F
Vaccine: UNK
Symptoms: Arthralgia, Gait disturbance, Muscle spasms, Myalgia, Pain
Clinical narrative: Began having pain in L sacral area and L hip which radiated to foot.  Pain spread to R sacral area and radiated down to right foot.  Had spasms, severe muscle pain in both legs.  Pain not relieved by Tylenol, Motrin, heating pad or rest.  Was unable to walk without holding onto wall. Lasted for 5-6 days.
Age: 64.0
Sex: F
Vaccine: UNK
Symptoms: Pain in extremity, Sacral pain
Clinical narrative: Began having pain in L sacral area and L hip which radiated to foot.  Pain spread to R sacral area and radiated down to right foot.  Had spasms, severe muscle pain in both legs.  Pain not relieved by Tylenol, Motrin, heating pad or rest.  Was unable to walk without holding onto wall. Lasted for 5-6 days.
Age: 80.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute kidney injury, Blood creatinine increased, Blood gases, Blood lactic acid increased, Blood urea normal
Clinical narrative: Chills, rigors, fever 104F, nausea (no vomiting), mild SOB.
Age: 80.0
Sex: M
Vaccine: COVID19-2
Symptoms: Blood urine absent, Brain natriuretic peptide normal, C-reactive protein normal, Chest X-ray normal, Chills
Clinical narrative: Chills, rigors, fever 104F, nausea (no vomiting), mild SOB.
Age: 80.0
Sex: M
Vaccine: COVID19-2
Symptoms: Computerised tomogram abdomen abnormal, Computerised tomogram thorax abnormal, Dyspnoea, Fibrin D dimer, Hypovolaemia
Clinical narrative: Chills, rigors, fever 104F, nausea (no vomiting), mild SOB.
Age: 80.0
Sex: M
Vaccine: COVID19-2
Symptoms: Lung opacity, Nausea, Neutrophil count increased, Neutrophilia, Nitrite urine absent
Clinical narrative: Chills, rigors, fever 104F, nausea (no vomiting), mild SOB.
Age: 80.0
Sex: M
Vaccine: COVID19-2
Symptoms: Procalcitonin normal, Pyrexia, Red blood cell sedimentation rate normal, Red blood cells urine negative, Sepsis
Clinical narrative: Chills, rigors, fever 104F, nausea (no vomiting), mild SOB.
Age: 80.0
Sex: M
Vaccine: COVID19-2
Symptoms: Troponin normal, Urine analysis normal, Urine leukocyte esterase, White blood cell count increased, White blood cells urine negative
Clinical narrative: Chills, rigors, fever 104F, nausea (no vomiting), mild SOB.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Asthenia, COVID-19, Cough, Dyspnoea
Clinical narrative: Discharge Provider: MD Primary Care Provider:  MD Admission Date: 9/13/2022 Discharge Date: Sep 15, 2022  PRESENTING PROBLEM: Generalized weakness [R53.1] COVID-19 virus infection [U07.1]   HOSPITAL COURSE: patient presented with shortness of breath after being diagnosed with COVID six days prior; he was found to be weak so was admitted for this. patient had a cough, nausea, vomiting, and hiccups as well. he was treated conservatively and PT/OT as well as SLP were asked to see him. SLP recommended GI evaluation as patient c/o of food being regurgitated or sticking in his chest; esophogram was normal and GI signed-off recommending PRN follow-up. patient's hiccups improved with thorazine and after a d/w pharmacy protonix was added (to be taken for 30 days) as an adjunct to treat said hiccups. patient had a bit of an AKI (he has a solitary kidney and CKD with baseline of 2.2) which improved with IVF. d-dimer elevation attributed to COVID as his symptoms improved without VTE intervention and a BLLE venous doppler was negative. patient was amenable for discharge citing that he felt less short of breath, was coughing less, and had less hiccups. he was still feeling a bit weak. all questions and concerns addressed, all meds and follow-ups reviewed.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Fibrin D dimer increased, Hiccups, Nausea, Oesophagram, Regurgitation
Clinical narrative: Discharge Provider: MD Primary Care Provider:  MD Admission Date: 9/13/2022 Discharge Date: Sep 15, 2022  PRESENTING PROBLEM: Generalized weakness [R53.1] COVID-19 virus infection [U07.1]   HOSPITAL COURSE: patient presented with shortness of breath after being diagnosed with COVID six days prior; he was found to be weak so was admitted for this. patient had a cough, nausea, vomiting, and hiccups as well. he was treated conservatively and PT/OT as well as SLP were asked to see him. SLP recommended GI evaluation as patient c/o of food being regurgitated or sticking in his chest; esophogram was normal and GI signed-off recommending PRN follow-up. patient's hiccups improved with thorazine and after a d/w pharmacy protonix was added (to be taken for 30 days) as an adjunct to treat said hiccups. patient had a bit of an AKI (he has a solitary kidney and CKD with baseline of 2.2) which improved with IVF. d-dimer elevation attributed to COVID as his symptoms improved without VTE intervention and a BLLE venous doppler was negative. patient was amenable for discharge citing that he felt less short of breath, was coughing less, and had less hiccups. he was still feeling a bit weak. all questions and concerns addressed, all meds and follow-ups reviewed.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Ultrasound Doppler, Vomiting
Clinical narrative: Discharge Provider: MD Primary Care Provider:  MD Admission Date: 9/13/2022 Discharge Date: Sep 15, 2022  PRESENTING PROBLEM: Generalized weakness [R53.1] COVID-19 virus infection [U07.1]   HOSPITAL COURSE: patient presented with shortness of breath after being diagnosed with COVID six days prior; he was found to be weak so was admitted for this. patient had a cough, nausea, vomiting, and hiccups as well. he was treated conservatively and PT/OT as well as SLP were asked to see him. SLP recommended GI evaluation as patient c/o of food being regurgitated or sticking in his chest; esophogram was normal and GI signed-off recommending PRN follow-up. patient's hiccups improved with thorazine and after a d/w pharmacy protonix was added (to be taken for 30 days) as an adjunct to treat said hiccups. patient had a bit of an AKI (he has a solitary kidney and CKD with baseline of 2.2) which improved with IVF. d-dimer elevation attributed to COVID as his symptoms improved without VTE intervention and a BLLE venous doppler was negative. patient was amenable for discharge citing that he felt less short of breath, was coughing less, and had less hiccups. he was still feeling a bit weak. all questions and concerns addressed, all meds and follow-ups reviewed.
Age: 5.0
Sex: F
Vaccine: UNK
Symptoms: Rash, Urticaria
Clinical narrative: patient received the COVID vaccine at 10:30 am today and developed a rash a few hours later at school. Rash images were sent to PCP and appear to be hives. No other symptoms at this time related to the vaccine
Age: 24.0
Sex: F
Vaccine: FLU4
Symptoms: Blood pressure increased, Chest discomfort, Dizziness, Dyspnoea, Hyperhidrosis
Clinical narrative: Dizziness, SOB, heaviness to chest, diophratic, tachycardia, elevated BP, unresponsive  911 called epi given
Age: 24.0
Sex: F
Vaccine: FLU4
Symptoms: Tachycardia, Unresponsive to stimuli
Clinical narrative: Dizziness, SOB, heaviness to chest, diophratic, tachycardia, elevated BP, unresponsive  911 called epi given
Age: 65.0
Sex: F
Vaccine: COVID19-2
Symptoms: Rash
Clinical narrative: You would need to contact the pharmacy, as I called them today and they advised me to wait a few days to see if rash goes away and if it persisted, I should see the Dr.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: ADMINISTERED PRIZER-BIONTECH NON BIVALENT BOOSTER
Age: 3.0
Sex: M
Vaccine: FLU4
Symptoms: Vaccination error
Clinical narrative: 3 year old moved when I attempted to give his shot into the left arm and the needle came out of his arm. Vaccine was given in his right arm.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: ADMINISTERED MODERNA NON BIVALENT BOOSTER
Age: 61.0
Sex: F
Vaccine: COVID19-2
Symptoms: Arthralgia, Chills, Fatigue, Headache, Myalgia
Clinical narrative: Chills, nausea, fever, joint aches, muscle aches, headache, and fatigue all within 24 hours; 48 hours later, a rash on the elbow of the arm where the vaccine was received.
Age: 61.0
Sex: F
Vaccine: COVID19-2
Symptoms: Nausea, Pyrexia, Vaccination site rash
Clinical narrative: Chills, nausea, fever, joint aches, muscle aches, headache, and fatigue all within 24 hours; 48 hours later, a rash on the elbow of the arm where the vaccine was received.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: The patient received a dose of covid booster that was from a vial that had been opened the previous day. The patient was called and informed the same day and no adverse reaction was reported by the patient.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: ADMINISTERED PFIZER-BIONTECH NON BIVALENT BOOSTER
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: ADMINISTERED PFIZER-BIONTECH NON BIVALENT BOOSTER
Age: 17.0
Sex: M
Vaccine: MENB, MNQ
Symptoms: Blood glucose decreased, Blood test abnormal, Chest X-ray abnormal, Chills, Dyspnoea
Clinical narrative: Per his mother , the patient experienced vomiting, chills, hallucinations, left sided numbness of the face and body and difficulty breathing. The patient was taken by ambulance the the emergency department.
Age: 17.0
Sex: M
Vaccine: MENB, MNQ
Symptoms: Hallucination, Hypoaesthesia, Pleurisy, Vomiting
Clinical narrative: Per his mother , the patient experienced vomiting, chills, hallucinations, left sided numbness of the face and body and difficulty breathing. The patient was taken by ambulance the the emergency department.
Age: 32.0
Sex: F
Vaccine: COVID19-2
Symptoms: Vaccination error
Clinical narrative: On 9/14/22 around 5:30 pm. The patient stated via translator (son) that she already received the first two doses. Consequently, the patient received Pfizer Bivalent as the first dose. The patient had not received the primary series per protocol. There were no adverse reactions. On 9/19/22 the patient was followed up with a call from a translator and nurse. It was verified that the patient only received one dose and that was the Bivalent Pfizer. The CDC  policy was used for vaccine administration errors.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Asthenia, Back pain, Caesarean section, Chest X-ray
Clinical narrative: Flu like symptoms at time of vaccination to include: Body aches. Shivers. Fever. Headache.  I was approximately 10 weeks pregnant at the time of the vaccination. My son was born on October 5th 2021 at 9lb 5oz. He was breached and born via c-section after 26 hours of induced labor.  For months prior I have been struggling with lightheadedness, dizziness with tunnel vision, extreme lack of energy. 4 September 2021 I was diagnosed with Pleurodynia after severe chest pains along with pain to my back and left shoulder. Unable to breathe I reported to the Hospital. I was prescribed Prednisone and Acetaminophen w/ Codeine. On 9 September I reported to the Medical Clinic after having severe pains during that week. They re-diagnosed me with Pericarditis and prescribed me 1000mg Naproxen for 1 month and Colcrys for 3 months.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Chills, Computerised tomogram thorax abnormal, Culture urine, Differential white blood cell count
Clinical narrative: Flu like symptoms at time of vaccination to include: Body aches. Shivers. Fever. Headache.  I was approximately 10 weeks pregnant at the time of the vaccination. My son was born on October 5th 2021 at 9lb 5oz. He was breached and born via c-section after 26 hours of induced labor.  For months prior I have been struggling with lightheadedness, dizziness with tunnel vision, extreme lack of energy. 4 September 2021 I was diagnosed with Pleurodynia after severe chest pains along with pain to my back and left shoulder. Unable to breathe I reported to the Hospital. I was prescribed Prednisone and Acetaminophen w/ Codeine. On 9 September I reported to the Medical Clinic after having severe pains during that week. They re-diagnosed me with Pericarditis and prescribed me 1000mg Naproxen for 1 month and Colcrys for 3 months.